Telesis Bio, Inc. (TBIO)
USD 0.43
(50.88%)
USD 0.43
(50.88%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 40.87 Million USD | 17.46% |
| 2022 | 34.79 Million USD | 36.6% |
| 2021 | 25.47 Million USD | -51.31% |
| 2020 | 52.32 Million USD | 13.09% |
| 2019 | 46.26 Million USD | -71.5% |
| 2018 | 162.35 Million USD | -44.41% |
| 2017 | 292.06 Million USD | 19.62% |
| 2016 | 244.15 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 42.78 Million USD | 2.64% |
| 2024 Q1 | 41.68 Million USD | 1.98% |
| 2023 Q1 | 52.54 Million USD | 51.0% |
| 2023 Q4 | 40.87 Million USD | -30.18% |
| 2023 Q2 | 86.61 Million USD | 64.84% |
| 2023 FY | 40.87 Million USD | 17.46% |
| 2023 Q3 | 58.54 Million USD | -32.41% |
| 2022 Q3 | 34.83 Million USD | 6.97% |
| 2022 Q4 | 34.79 Million USD | -0.11% |
| 2022 FY | 34.79 Million USD | 36.6% |
| 2022 Q1 | 33.03 Million USD | 29.68% |
| 2022 Q2 | 32.56 Million USD | -1.42% |
| 2021 Q3 | 21.73 Million USD | -9.37% |
| 2021 Q1 | 64.01 Million USD | 22.36% |
| 2021 FY | 25.47 Million USD | -51.31% |
| 2021 Q4 | 25.47 Million USD | 17.21% |
| 2021 Q2 | 23.98 Million USD | -62.54% |
| 2020 Q2 | 182.88 Million USD | 12.5% |
| 2020 Q4 | 52.32 Million USD | -90.36% |
| 2020 Q3 | 542.96 Million USD | 196.89% |
| 2020 Q1 | 162.57 Million USD | -11.0% |
| 2020 FY | 52.32 Million USD | 13.09% |
| 2019 Q3 | 167.94 Million USD | -10.12% |
| 2019 Q1 | 182.62 Million USD | 12.49% |
| 2019 FY | 46.26 Million USD | -71.5% |
| 2019 Q4 | 182.66 Million USD | 8.77% |
| 2019 Q2 | 186.85 Million USD | 2.31% |
| 2018 Q1 | 101.86 Million USD | -65.12% |
| 2018 FY | 162.35 Million USD | -44.41% |
| 2018 Q4 | 162.35 Million USD | -7.32% |
| 2018 Q3 | 175.17 Million USD | -42.52% |
| 2018 Q2 | 304.74 Million USD | 199.16% |
| 2017 FY | 292.06 Million USD | 19.62% |
| 2017 Q4 | 292.06 Million USD | 0.0% |
| 2016 FY | 244.15 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 20.254% |
| BrainsWay Ltd. | 15.31 Million USD | -166.9% |
| Cerus Corporation | 144.3 Million USD | 71.676% |
| Envoy Medical, Inc. | 9.4 Million USD | -334.727% |
| electroCore, Inc. | 8.94 Million USD | -356.937% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -665.125% |
| IceCure Medical Ltd | 4.24 Million USD | -862.397% |
| Inogen, Inc. | 121.38 Million USD | 66.327% |
| OrthoPediatrics Corp. | 72.56 Million USD | 43.671% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -38.173% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -1184.53% |
| MaxCyte, Inc. | 36.1 Million USD | -13.2% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -2111.85% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -9510.822% |
| Orthofix Medical Inc. | 326.58 Million USD | 87.485% |
| PAVmed Inc | 57.13 Million USD | 28.465% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -60.519% |
| RxSight, Inc. | 22.18 Million USD | -84.212% |
| Sight Sciences, Inc. | 46.43 Million USD | 11.98% |
| SI-BONE, Inc. | 61.05 Million USD | 33.05% |
| TELA Bio, Inc. | 59.16 Million USD | 30.919% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 64.137% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -296.095% |
| Acutus Medical, Inc. | 54.83 Million USD | 25.467% |
| Talis Biomedical Corporation | 29.22 Million USD | -39.861% |
| Spectral AI, Inc. | 12.4 Million USD | -229.594% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -76.679% |
| CVRx, Inc. | 39.28 Million USD | -4.05% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -241.802% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -1582.501% |
| Bioventus Inc. | 589.79 Million USD | 93.07% |
| Venus Concept Inc. | 107.1 Million USD | 61.838% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 20.885% |
| LivaNova PLC | 1.15 Billion USD | 96.452% |
| 908 Devices Inc. | 37.49 Million USD | -9.024% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 94.19% |
| Nemaura Medical Inc. | 26.37 Million USD | -54.954% |
| NeuroPace, Inc. | 86.99 Million USD | 53.018% |
| LENSAR, Inc. | 22.4 Million USD | -82.395% |
| Apyx Medical Corporation | 52.31 Million USD | 21.876% |
| Cutera, Inc. | 518.12 Million USD | 92.111% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -39.365% |
| BioSig Technologies, Inc. | 4.68 Million USD | -772.423% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 29.972% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -90.213% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 98.137% |
| Axonics, Inc. | 82.35 Million USD | 50.372% |
| Outset Medical, Inc. | 190.91 Million USD | 78.591% |
| IRIDEX Corporation | 24.91 Million USD | -64.056% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 67.029% |
| IRadimed Corporation | 20.73 Million USD | -97.112% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -2341.637% |
| INVO Bioscience, Inc. | 19.99 Million USD | -104.416% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -0.203% |
| Varex Imaging Corporation | 668.6 Million USD | 93.887% |
| Quipt Home Medical Corp. | 136.29 Million USD | 70.011% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -1044.261% |
| Pulmonx Corporation | 60.63 Million USD | 32.593% |
| Dynatronics Corporation | 11.78 Million USD | -246.966% |
| Modular Medical, Inc. | 2.27 Million USD | -1698.988% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -905.733% |
| Semler Scientific, Inc. | 6.27 Million USD | -551.882% |
| InMode Ltd. | 75.91 Million USD | 46.159% |
| Bruker Corporation | 2.83 Billion USD | 98.559% |
| Cytosorbents Corporation | 29.98 Million USD | -36.309% |
| DexCom, Inc. | 4.19 Billion USD | 99.026% |
| Align Technology, Inc. | 2.45 Billion USD | 98.334% |
| Viveve Medical, Inc. | 10.84 Million USD | -276.814% |
| ZimVie Inc. | 795.85 Million USD | 94.864% |
| Movano Inc. | 5.97 Million USD | -584.411% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 60.926% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -9510.822% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -241.802% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 93.604% |
| Profound Medical Corp. | 12.66 Million USD | -222.702% |
| Insulet Corporation | 1.85 Billion USD | 97.797% |
| enVVeno Medical Corporation | 2.43 Million USD | -1578.563% |
| Surmodics, Inc. | 65.82 Million USD | 37.905% |
| iCAD, Inc. | 8 Million USD | -410.849% |
| Nuwellis, Inc. | 6.78 Million USD | -502.847% |
| Biotricity, Inc. | 35.91 Million USD | -13.791% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 81.675% |
| Aethlon Medical, Inc. | 2.47 Million USD | -1548.337% |
| InspireMD, Inc. | 8.14 Million USD | -402.002% |
| PAVmed Inc. | 57.13 Million USD | 28.465% |
| BIOLASE, Inc. | 35.34 Million USD | -15.63% |
| Beyond Air, Inc. | 29.77 Million USD | -37.273% |
| FONAR Corporation | 57.45 Million USD | 28.864% |
| AxoGen, Inc. | 101.16 Million USD | 59.596% |
| Vivani Medical, Inc. | 25.03 Million USD | -63.257% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 53.445% |
| Inari Medical, Inc. | 209.32 Million USD | 80.474% |
| UFP Technologies, Inc. | 118.04 Million USD | 65.375% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -222.076% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -1769.923% |
| Tenon Medical, Inc. | 5.56 Million USD | -634.202% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -2197.527% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -131.784% |
| AdaptHealth Corp. | 3.15 Billion USD | 98.704% |
| Sintx Technologies, Inc. | 6.59 Million USD | -519.945% |
| NanoVibronix, Inc. | 2.68 Million USD | -1421.705% |
| Quanterix Corporation | 78.08 Million USD | 47.655% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -1044.261% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -736.704% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 96.088% |
| TransMedics Group, Inc. | 568.84 Million USD | 92.815% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -145.013% |
| NeuroMetrix, Inc. | 1.33 Million USD | -2965.956% |
| Hyperfine, Inc. | 9.8 Million USD | -317.071% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 83.667% |
| Biomerica, Inc. | 2.66 Million USD | -1434.848% |
| Bone Biologics Corporation | 831.4 Thousand USD | -4816.154% |
| AVITA Medical, Inc. | 19.86 Million USD | -105.75% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -1970.9% |
| Silk Road Medical, Inc | 114.15 Million USD | 64.196% |